Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhei Kirita

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Nature Communications|July 13, 2023
Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretionYoshito Minami, Atsushi Hoshino, Yusuke Higuchi, et al.
American Journal of Physiology. Renal Physiology|August 18, 2020
Intratubular epithelial-mesenchymal transition and tubular atrophy after kidney injury in miceNoriyuki Yamashita, Tetsuro Kusaba, Tomohiro Nakata, et al.
Heliyon|September 23, 2022
Proximal tubular epithelia-specific transcriptomics of diabetic mice treated with dapagliflozinNoriko Uehara-Watanabe, Natsuko Okuno-Ozeki, Itaru Nakamura, et al.
Scientific Reports|March 12, 2020
Pharmacological inhibition of ataxia-telangiectasia mutated exacerbates acute kidney injury by activating p53 signaling in miceMasahiro Uehara, Tetsuro Kusaba, Tomoharu Ida, et al.
Scientific Reports|March 7, 2018
Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in miceMichitsugu Kamezaki, Tetsuro Kusaba, Kazumi Komaki, et al.
Kidney International|November 29, 2021
Kidney vascular congestion exacerbates acute kidney injury in miceTakashi Kitani, Kengo Kidokoro, Tomohiro Nakata, et al.
Scientific Reports|January 18, 2022
Direct evidence of proximal tubular proliferation in early diabetic nephropathyNoriko Uehara-Watanabe, Natsuko Okuno-Ozeki, Atsushi Minamida, et al.
Scientific Reports|July 2, 2025
Injured tubule derived CCN1 exacerbates renal congestion-mediated acute kidney injury and fibrosisAtsushi Minamida, Tomohiro Nakata, Ryo Kurose, et al.
Nature Communications|June 22, 2021
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
Science Translational Medicine|April 26, 2022
An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivoNariko Ikemura, Shunta Taminishi, Tohru Inaba, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Nature Communications|July 13, 2023
Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretionYoshito Minami, Atsushi Hoshino, Yusuke Higuchi, et al.
American Journal of Physiology. Renal Physiology|August 18, 2020
Intratubular epithelial-mesenchymal transition and tubular atrophy after kidney injury in miceNoriyuki Yamashita, Tetsuro Kusaba, Tomohiro Nakata, et al.
Heliyon|September 23, 2022
Proximal tubular epithelia-specific transcriptomics of diabetic mice treated with dapagliflozinNoriko Uehara-Watanabe, Natsuko Okuno-Ozeki, Itaru Nakamura, et al.
Scientific Reports|March 12, 2020
Pharmacological inhibition of ataxia-telangiectasia mutated exacerbates acute kidney injury by activating p53 signaling in miceMasahiro Uehara, Tetsuro Kusaba, Tomoharu Ida, et al.
Scientific Reports|March 7, 2018
Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in miceMichitsugu Kamezaki, Tetsuro Kusaba, Kazumi Komaki, et al.
Kidney International|November 29, 2021
Kidney vascular congestion exacerbates acute kidney injury in miceTakashi Kitani, Kengo Kidokoro, Tomohiro Nakata, et al.
Scientific Reports|January 18, 2022
Direct evidence of proximal tubular proliferation in early diabetic nephropathyNoriko Uehara-Watanabe, Natsuko Okuno-Ozeki, Atsushi Minamida, et al.
Scientific Reports|July 2, 2025
Injured tubule derived CCN1 exacerbates renal congestion-mediated acute kidney injury and fibrosisAtsushi Minamida, Tomohiro Nakata, Ryo Kurose, et al.
Nature Communications|June 22, 2021
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
Science Translational Medicine|April 26, 2022
An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivoNariko Ikemura, Shunta Taminishi, Tohru Inaba, et al.
Pageof 4